Analysis of 15 primary open-angle glaucoma families from Australia identifies a founder effect for the Q368STOP mutation of myocilin

被引:32
作者
Baird, PN
Craig, JE
Richardson, AJ
Ring, MA
Sim, P
Stanwix, S
Foote, SJ
Mackey, DA
机构
[1] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia
[2] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia
[3] Univ Tasmania, Menzies Ctr Populat Hlth Res, Hobart, Tas 7000, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1007/s00439-002-0865-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Primary open-angle glaucoma (POAG) is a leading cause of blindness in the world. A number of mutations in the myocilin gene have been identified that predispose to glaucoma. The most frequent of these is the Glutamine368STOP (Q368STOP) mutation. It has been postulated that individuals with the Q368STOP mutation are derived from a common founder. To clarify this situation, we studied 15 unrelated POAG families who carried the Q368STOP mutation, from south eastern Australia. In one large family, nine affected and ten unaffected individuals were identified with the Q368STOP mutation. Closely linked polymorphic microsatellite markers were used to establish a disease haplotype in this family. Additional genotyping of markers in another 14 unrelated Q368STOP families revealed the presence of the same disease haplotype. These findings indicate that the Q368STOP mutation in all 15 families shared a common origin prior to the European settlement of Australia in the early 1800s.
引用
收藏
页码:110 / 116
页数:7
相关论文
共 25 条
[1]   Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma [J].
Adam, MF ;
Belmouden, A ;
Binisti, P ;
Brezin, AP ;
Valtot, F ;
Bechetoille, A ;
Dascotte, JC ;
Copin, B ;
Gomez, T ;
Chaventre, A ;
Bach, JF ;
Garchon, HJ .
HUMAN MOLECULAR GENETICS, 1997, 6 (12) :2091-2097
[2]  
Allingham RR, 1998, INVEST OPHTH VIS SCI, V39, P2288
[3]   Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLCIA) [J].
Alward, WLM ;
Fingert, JH ;
Coote, MA ;
Johnson, AT ;
Lerner, SF ;
Junqua, D ;
Durcan, FJ ;
McCartney, PJ ;
Mackey, DA ;
Sheffield, VC ;
Stone, EM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (15) :1022-1027
[4]  
Angius A, 2000, ARCH OPHTHALMOL-CHIC, V118, P674
[5]   The Taa1 restriction enzyme provides a simple means to identify the Q368STOP mutation of the myocilin gene in primary open angle glaucoma [J].
Baird, PN ;
Dickinson, J ;
Craig, JE ;
Mackey, DA .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (04) :510-511
[6]   Modulation of non-templated nucleotide addition by taq DNA polymerase: Primer modifications that facilitate genotyping [J].
Brownstein, MJ ;
Carpten, JD ;
Smith, JR .
BIOTECHNIQUES, 1996, 20 (06) :1004-+
[7]   Rapid mutation detection by the Transgenomic wave analyser DHPLC identifies MYOC mutations in patients with ocular hypertension and/or open angle glaucoma [J].
Cobb, CJ ;
Scott, G ;
Swingler, RJ ;
Wilson, S ;
Ellis, J ;
MacEwen, CJ ;
McLean, WHI .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (02) :191-195
[8]   Evidence for genetic heterogeneity within eight glaucoma families, with the GLC1A Gln368STOP mutation being an important phenotypic modifier [J].
Craig, JE ;
Baird, PN ;
Healey, DL ;
McNaught, AI ;
McCartney, PJ ;
Rait, JL ;
Dickinson, JL ;
Roe, L ;
Fingert, JH ;
Stone, EM ;
Mackey, DA .
OPHTHALMOLOGY, 2001, 108 (09) :1607-1620
[9]  
Dickinson J L, 2001, Ophthalmic Genet, V22, P49, DOI 10.1076/opge.22.1.49.2240
[10]  
Faucher M, 2001, INVEST OPHTH VIS SCI, V42, pS562